Azvudine producer cuts price, boosts access

China’s first oral anti-COVID-19 drug Azvudine will be covered by China's national medical insurance system after negotiations, China's National Healthcare Security Administration said Sunday evening.

Related Keywords

China ,Henan ,Chinese ,Wang Chaoyang ,Liu Yong ,Photo China News Service ,China National Healthcare Security Administration ,Henan Genuine Biotech ,China News Service ,National Healthcare Security Administration ,Genuine Biotech ,